1.
Nurachman A. PHARMACOVIGILANCE AND OFF-GUIDELINE USE FOR GABAPENTIN IN FIBROMYALGIA: A REVIEW OF SAFETY PROFILES AND PRESCRIBING PATTERNS. JRPPS [Internet]. 2025 Jun. 19 [cited 2025 Dec. 6];4(1):31-42. Available from: https://ejournal.upnvj.ac.id/JRPPS/article/view/11312